DrugPatentWatch

Search for Therapeutic Class: Inflammatory Bowel Disease Agents

Ingredients / Generics in Therapeutic Class: Inflammatory Bowel Disease Agents

betamethasone acetate; betamethasone sodium phosphate    budesonide    cortisone acetate   
Glossary
Applicant Tradename Generic Name NDA Approval Date Type RLD Patent Number Product Substance Delist Req. Patent Expiration Exclusivity Expiration
LuitpoldBETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATEbetamethasone acetate; betamethasone sodium phosphate090747Jul 31, 2009RXNo
ScheringCELESTONE SOLUSPANbetamethasone acetate; betamethasone sodium phosphate014602Approved Prior to Jan 1, 1982RXYes
AstrazenecaRHINOCORTbudesonide020233Feb 14, 1994DISCNNo
Export available with Ultimate Plan subscription: 

This preview shows a limited data set. Complete access is available with a Subscription

<- Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
 2000  2001  2002  2003  2004 
 2005  2006  2007  2008  2009 


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.


[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Patent Inventor Report | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]